InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.240 0.005 (2.04%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$203 EBR Executives to Speak at Upcoming Investor Conferences 20 Oct 2025 9:06AM $1.345 $0.240 fallen by 82.16%
$203 Notification of cessation of securities - EBR 15 Oct 2025 9:38AM $1.270 $0.240 fallen by 81.10%
$203 Notification regarding unquoted securities - EBR 14 Oct 2025 11:07AM $1.305 $0.240 fallen by 81.61%
$203 Application for quotation of securities - EBR 10 Oct 2025 2:52PM $1.293 $0.240 fallen by 81.43%
$203 Drug & Device Conference Presentation 9 Oct 2025 9:06AM $1.280 $0.240 fallen by 81.25%
$203 Investor Roadshow 9 Oct 2025 9:01AM $1.280 $0.240 fallen by 81.25%
$203 HealthInvest 2025 Investor Presentation 22 Sep 2025 10:10AM $1.220 $0.240 fallen by 80.33%
$203 Final CMS Approval Received for TPT Reimbursement 22 Sep 2025 10:06AM $1.220 $0.240 fallen by 80.33%
$203 EBR Passes Tenth US Commercial Implant Milestone 17 Sep 2025 9:11AM $1.170 $0.240 fallen by 79.49%
$203 Notification of cessation of securities - EBR 15 Sep 2025 11:03AM $1.170 $0.240 fallen by 79.49%
$203 Notification regarding unquoted securities - EBR 11 Sep 2025 3:21PM $1.110 $0.240 fallen by 78.38%
$203 Application for quotation of securities - EBR 10 Sep 2025 10:22AM $1.120 $0.240 fallen by 78.57%
$203 Change of Director's Interest Notice 21 Aug 2025 9:28AM $1.250 $0.240 fallen by 80.80%
$203 Application for quotation of securities - EBR 21 Aug 2025 9:24AM $1.250 $0.240 fallen by 80.80%
$203 Q2 2025 Form 10-Q submission and Quarterly Activity Report 13 Aug 2025 8:25AM $1.350 $0.240 fallen by 82.22%
$203 Canaccord Growth Conference Investor Presentation 11 Aug 2025 9:37AM $1.385 $0.240 fallen by 82.67%
$203 EBR to Participate at Canaccord Genuity Annual Conference 8 Aug 2025 9:39AM $1.390 $0.240 fallen by 82.73%
$203 Notification regarding unquoted securities - EBR 8 Aug 2025 9:34AM $1.390 $0.240 fallen by 82.73%
$203 Final CMS Approval Received for NTAP Reimbursement 5 Aug 2025 9:21AM $1.340 $0.240 fallen by 82.09%
$203 Notification of cessation of securities - EBR 21 Jul 2025 9:43AM $1.255 $0.240 fallen by 80.88%
$203 Notification regarding unquoted securities - EBR 18 Jul 2025 9:24AM $1.240 $0.240 fallen by 80.65%
$203 Application for quotation of securities - EBR 17 Jul 2025 8:42AM $1.260 $0.240 fallen by 80.95%
$203 Preliminary Approval for TPT Reimbursement Received 15 Jul 2025 9:10AM $1.175 $0.240 fallen by 79.57%
$203 Appointment of Australian Company Secretary 30 Jun 2025 12:34PM $1.208 $0.240 fallen by 80.12%
$203 Notification regarding unquoted securities - EBR 26 Jun 2025 9:27AM $1.150 $0.240 fallen by 79.13%

101 - 125 of 504 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.